ABN Amro Investment Solutions Sells 93,474 Shares of Corteva, Inc. $CTVA

ABN Amro Investment Solutions cut its stake in shares of Corteva, Inc. (NYSE:CTVA) by 59.4% in the 1st quarter, Holdings Channel reports. The institutional investor owned 63,821 shares of the company’s stock after selling 93,474 shares during the quarter. ABN Amro Investment Solutions’ holdings in Corteva were worth $5,342,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. JPL Wealth Management LLC bought a new stake in Corteva during the 3rd quarter worth $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva during the fourth quarter worth about $27,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva in the fourth quarter valued at approximately $28,000. Cornerstone Financial Management LLC bought a new position in Corteva in the 4th quarter valued at approximately $29,000. Finally, Basepoint Wealth LLC acquired a new stake in Corteva during the 4th quarter worth approximately $30,000. 81.54% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CTVA shares. Royal Bank Of Canada raised their price target on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday. Citigroup lifted their target price on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. BNP Paribas Exane upped their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Bank of America upped their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday. Finally, Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $89.90.

Corteva Trading Up 1.9%

CTVA opened at $88.56 on Thursday. The company has a fifty day moving average price of $81.13 and a two-hundred day moving average price of $78.69. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $88.57. The company has a market cap of $59.23 billion, a P/E ratio of 52.09, a price-to-earnings-growth ratio of 2.64 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 3.75 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.